Ultrasound-guided percutaneous injection of lauromacrogol to treat benign thyroid cysts

DAI Xiuling; SUN Yongkang; SHI Qian; GUO Jia

您当前的位置：

首页 >

文章列表页 >

Ultrasound-guided percutaneous injection of lauromacrogol to treat benign thyroid cysts

更新时间：2026-06-18

- Ultrasound-guided percutaneous injection of lauromacrogol to treat benign thyroid cysts
- Vol. 26, Issue 5, Pages: 354-357(2017)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  CLC：
- Online First：08 December 2017，
  
  Published：08 December 2017
- 稿件说明：
移动端阅览
代秀玲,孙永康,施倩,等. 超声引导下聚桂醇硬化治疗甲状腺囊性结节的疗效研究[J]. 肿瘤影像学, 2017, 26(5): 354-357
DOI：

代秀玲,孙永康,施倩,等. 超声引导下聚桂醇硬化治疗甲状腺囊性结节的疗效研究[J]. 肿瘤影像学, 2017, 26(5): 354-357 DOI：

摘要

目的：

探讨超声引导下聚桂醇硬化治疗甲状腺囊性结节的疗效及安全性。

方法：

纳入38个甲状腺囊性结节，其中部分为囊实混合性结节，囊性部分＞80%，患者均进行超声引导下聚桂醇硬化治疗。术后观察患者反应30 min，并于术后1、3个月进行超声复查，测量囊肿大小并与治疗前比较，以囊肿体积缩小2/3以上为有效。观察和记录所有患者术中及术后不良反应和并发症，对术前及术后随访中结节长径和体积的变化用SPSS 19.0统计学软件进行配对t检验，

＜0.05为差异有统计学意义。

结果：

38个结节在治疗后1个月的有效率为63.16%(24/38)；治疗后3个月的有效率为100%(38/38)。

结论：

超声引导下聚桂醇硬化治疗甲状腺囊性结节的成功率高，治疗效果好，并发症少，操作简便，具有较好的应用前景，值得在临床推广和应用。

Abstract

Objective:

To investigate the value of ultrasound-guided percutaneaus injection of lauromacrogol in the treatment of benign thyroid cysts.

Methods:

A total of 38 patients with 38 benign thyroid cysts were included and all patients were scheduled to undergo sclero therapy using lauromacrogol. Most of the nodules were pure cysts and a small portion of them were cyst/solid with cyst portion 80%. All patients were kept in hospital for more than 30 min to observe the possible complications and were followed up. The standard of effective treatment was that the volume of cyst shrank to 1/3

and the standard of healing was that the cyst disappeared totally. The results were statistically analyzed by SPSS 19.0 and

0.05 was considered as significant..

Results:

All 38 nodules were injected with lauromacrogol. After 1 month the efficacy was 63.16% (24/38). After 3 months the efficacy reached 100% (38/38). No patient presented complications and the overall healing rate was 100%.

Conclusion:

Ultrasound-guided percutaneous injection of lauromacrogol to treat benign thyroid cysts is effective

convenient and safe with a promising future.

关键词

Keywords

references

Views

1824

下载量

CNKI被引量

Alert me when the article has been cited

提交

Tools

Publicity Resources

Research progress on ultrasound-guided chemical ablation for thyroid cystic and cystic-solid nodules

Ultrasound-guided treatment of predominantly cystic thyroid nodules: a comparative study between lauromacrogol injection therapy and radiofrequency ablation

Comparative study of C-TIRADS, shear-wave elastography, and artificial intelligence in size-stratified diagnosis of thyroid nodules

Multivariate analysis of ultrasonographic characteristics for differentiating benign and malignant BethesdaⅢ category thyroid nodules

Diagnostic value of contrast-enhanced ultrasound combined with fine-needle aspiration biopsy in thyroid TI-RADS 4 nodules

Related Author

TAO Ruolin

ZHOU Jianqiao

WU Fan

CHEN Yaqing

HE Zheng

ZHU Yunkai

GAO Zhiling

ZHOU Jing

Related Institution

Department of Ultrasound, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

Department of Ultrasound, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

The First Department of Ultrasound, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine

Department of Ultrasound, Tangshan People’s Hospital

Department of Ultrasound, The Fourth Affiliated Hospital of Nanjing Medical University

AI问答

⁰